Related Experiment Video
Updated: Aug 8, 2025

Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway
Published on: August 23, 2024
A Case of Castleman's Disease during the Long-Term Course of Membranous Nephropathy
Shuhei Nakajima1, Kei Nagai1,2, Akiko Sakata3
1Department of Nephrology, Hitachi General Hospital, 2-1-1 Jonan-cho, Hitachi, Ibaraki 317-0077, Japan.
Abstract:
Concomitant with nephrotic syndrome and multicentric castleman's disease (MCD) has only been described in a limited number of small studies and case reports. Among those, none confirmed the renal pathology prior to the onset of MCD, and none of the cases had a history of nephrotic syndrome. A 76 year-old Japanese man visited a nephrologist because of incident nephrotic syndrome. He had previously experienced three episodes of nephrotic syndrome, the last one 13 years ago, and had been diagnosed with membranous nephropathy by renal biopsy. Apart from these previous episodes, he also suffered from systemic lymphadenopathy, anemia, elevated C-reactive protein, polyclonal hypergammopathy, and elevated interleukin (IL)-6. An inguinal lymph node biopsy revealed CD138-positive plasma cells in the interfollicular region. Based on these findings, MCD was diagnosed. Renal biopsy indicated primary membranous nephropathy with spike lesions and bubbling in the basement membranes and deposition of immunoglobulin (Ig) G, IgA, IgM, and phospholipase A2 receptor along the glomerular basement membrane. Corticosteroid monotherapy successfully reduced the edema, proteinuria, and IL-6, but hypoalbuminemia was not sufficiently improved due to castleman's disease and remission of the nephrotic syndrome was not achieved. Later, tocilizumab was administered for remission induction in another facility. To the best of our knowledge, this represents the first report of Castleman's disease with previously diagnosed membranous nephropathy. This case does not provide a causal mechanism for the pathophysiology, but it may be worth suggesting possible involvement of MCD as a trigger for recurrence of membranous nephropathy.
Insights
This case report details a patient with a history of membranous nephropathy who developed multicentric Castleman's disease (MCD). It suggests MCD may trigger recurrent nephrotic syndrome, highlighting a novel association.
Area of Science:
- Nephrology
- Hematology
- Immunology
Background:
- Multicentric Castleman's disease (MCD) and nephrotic syndrome co-occurrence is rarely documented.
- Previous reports lack confirmed renal pathology before MCD onset or a history of nephrotic syndrome.
Observation:
- A 76-year-old man with a history of membranous nephropathy presented with nephrotic syndrome.
- Diagnostic workup revealed systemic lymphadenopathy, elevated IL-6, and CD138-positive plasma cells, leading to an MCD diagnosis.
- Renal biopsy confirmed primary membranous nephropathy with specific immunoglobulin depositions.
Findings:
- Corticosteroid therapy partially improved symptoms but did not achieve full remission.
- Tocilizumab was later administered for remission induction.
- This is the first reported case of Castleman's disease in a patient with pre-existing membranous nephropathy.
Implications:
- The findings suggest a potential role for MCD in triggering recurrent membranous nephropathy.
- Further research is needed to elucidate the pathophysiological link between MCD and nephrotic syndrome recurrence.
Related Concept Videos
Chronic Kidney Disease II: Clinical Manifestations
Acute Kidney Injury III: Clinical Manifestations
Nephrotic Syndrome I : Introduction
Chronic Kidney Disease III: Interprofessional Care
Nephrotic Syndrome II : Assessment and Medical Management
Chronic Kidney Disease IV: Nursing Management

